Hoyer PB. Reproductive toxicology: current and future directions. Biochem Pharmacol 2001. 62: 1557-1564.

Fox Aw, Yang X, Murli H, Lawlor TE, Cifone MA, Reno FE, Absence of mutagenic effects of sodium dichloroacetate. Fund Appl Tox 1996; 32: 87-95.

Kowalski LA. In vitro carcinogenicity testing: present and future perspectives in pharmaceutical development. Cure Opin Drug Discov Devel 2001; 4: 29-35.

Tennat RW, Stasiewicz S, Spalding JW. Comparison of Multiple parameters of rodent carcinogenicity and in vitro genetic toxicity Environ Mutagen 1986; 8: 205-227.

Peck CC, Barr WH, Benet LZ et al. Opportunities for integration of pharmacokinetics, Pharmacodynamics, and toxicokinetics in rational drug development. Clin Pharmacol Ther 1992; 51: 465-473.

Reno FE (1997) Carcinogenicity Studies. In Comprehensive Toxicology, vol 2, Toxicological Testing and Evaluation, Williams PD, Hottendorf GH (eds), Elsevier: London; 121-31.

Terrell TG, Green JD (1994) Issues with biotechnology products in toxicologic pathology. Toxicol Pathol 22: 187-93.

Voisin EM, Ruthsatz M, Collins JM, Hoyle PC (1990) Extrapolation of animal toxicity to humans: interspecies comparisons in drug development. Regulat Toxicol Pharmacol 12: 107-16.

Williams PD, Hottendof GH, (Eds.) Comprehensive Toxicology Vol.2: Toxicological testing & Evaluation. Elsevier: London, 1997.

0 0

Post a comment